Valeant To Hold Conference Call To Present Fourth Quarter And Full Year 2016 Results And Announce 2017 Guidance

LAVAL, Quebec, Jan. 30, 2017 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced that it plans to hold a conference call and live webcast on Tuesday, February 28, 2017 at 8:00 a.m. ET. The Company will discuss fourth quarter and full year 2016 financial results, and announce 2017 guidance during the presentation.  Related materials will be made available on the investor relations portion of the corporate website before the start of the conference call.

Conference Call Details


Tuesday, February 28, 2017


8:00 a.m. ET


Participant Event Dial-in 

(877) 876-8393 (North America)

(443) 961-0178 (International) 

Participant Passcode


Replay Dial-in

(855) 859-2056 (North America)

(404) 537-3406 (International) 

Replay Passcode

63999208 (replay available until 03/31/2017)


About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at

Contact Information:
Elif McDonald
877-281-6642 (toll free)

Renée Soto or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.


SOURCE Valeant Pharmaceuticals International, Inc.

To view this news release in HTML formatting, please use the following URL:

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890